Cited by 4Microbial Metabolic Engineering and BioproductionBioinformatics and Genomic NetworksGene Regulatory Network Analysis

A personalized metabolic modelling approach through integrated analysis of RNA-Seq-based genomic variants and gene expression levels in Alzheimer’s disease

Open access
Uzuner Odongo, Dilara, İlgün, Atılay, Bozkurt, Fatma Betül, Çakır, Tunahan·2025·Communications Biology

Published version of a preprint

Abstract

Abstract Motivation Alzheimer’s disease (AD) is known to cause alterations in brain metabolism. Furthermore, genomic variants in enzyme-coding genes may exacerbate AD-linked metabolic changes. Generating condition-specific metabolic models by mapping gene expression data to genome-scale metabolic models is a routine approach to elucidate disease mechanisms from a metabolic perspective. RNAseq data provides both gene expression and genomic variation information. Integrating variants that perturb enzyme functionality from the same RNAseq data may enhance model accuracy, offering insights into genome-wide AD metabolic pathology. Results Our study pioneers the extraction of both transcriptomic and genomic data from the same RNA-seq data to reconstruct personalized metabolic models. We mapped genes with significantly higher load of pathogenic variants in AD onto a human genome-scale metabolic network together with the gene expression data. Comparative analysis of the resulting personalized patient metabolic models with the control models showed enhanced accuracy in detecting AD-associated metabolic pathways compared to the case where only expression data was mapped on the metabolic network. Besides, several otherwise would-be missed pathways were annotated in AD by considering the effect of genomic variants. Implementation The scripts are available at https://github.com/SysBioGTU/GenomicVariantsMetabolicModels . Contact tcakir@gtu.edu.tr

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-025-07941-z

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AI-driven approaches have enabled more comprehensive analyses of mitochondrial gene expression profiles and metabolic pathway alterations.

    “AI-driven approaches have enabled more comprehensive analyses of mitochondrial gene expression profiles and metabolic pathway alterations47,48.”

    From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [48]

    In Results and discussion, under “Differentially perturbed pathways” (page not specified), the paper reports that models integrating genomic variants with gene-expression data identified more altered metabolic pathways than expression-only models. It does not establish that the approach was AI-driven or that it provided a more comprehensive analysis of mitochondrial gene-expression profiles. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 63 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. [1]Bhatia, S. et al. Mitochondrial dysfunction in Alzheimer’s disease: Opportunities for drug development. Curr. Neuropharmacol. 20, 675–692 (2022). 33998995 PMC9878959
  2. [15]Andrews, S. (Babraham Bioinformatics, Babraham Institute, Cambridge, United Kingdom, 2010).
  3. [21]Brouard, J.-S. & Bissonnette, N. Variant Calling: Methods and Protocols (eds C. Ng & S. Piscuoglio) 205-233 (Springer US, 2022). 35751817
  4. [26]Lüleci, et al. Alzheimer’s Disease: Methods and Protocols (ed J. Chun) 173–189 (Springer US, 2023).

Cited by

Sorted by citations

Authors
Uzuner Odongo, D., İlgün, A., Bozkurt, F. B., & Çakır, T.
Affiliations
Gebze Technical University (TR)
Corresponding author
Çakır, Tunahan
Venue
Communications Biology
Published
2025-03-27
Volume
8
Issue
1
Pages
502-502
ISSN
2399-3642 (ISSN-L)
OpenAlex
W4408912420
Cited by
4
References
63
Citations by year
2026: 2 · 2025: 2
FWCI
1.20
Type
journal article
Language
en
Open access
Locations
  • Communications Biology (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (100/2000, 120S824)
  • Yükseköğretim Kurulu (100/ 2000)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
Keywords
Alzheimer's disease, genome-scale metabolic models, RNA-seq, genetic variants, gene expression, pathogenic variants, metabolic pathways
MeSH terms
RNA-Seq, Alzheimer Disease, Humans, Models, Biological, Genetic Variation, Gene Expression Profiling, Genomics, Metabolic Networks and Pathways, Precision Medicine, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review